The disclosed investors in the Series A round of financing are Emerson Collective, Illumina Ventures, and Quan Capital. B cells are a type of white blood cell that produces antibodies. Walking Fish is ...
MaxCyte signed a strategic platform license (SPL) with Walking Fish Therapeutics which focuses on B cell-based therapeutics. Walking Fish obtains non-exclusive clinical and commercial rights to use ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Walking Fish Therapeutics, a leader in B cell engineering, today announced it has appointed Georgia Erbez as Chief Operating Officer and moved to a new 22 ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Walking Fish Therapeutics, a leader in B cell therapeutics, today announced the completion of an oversubscribed Series A financing, raising a total of $73 ...
“There are two main walking gaits. One resembles a traditional walk. The other is called crutching, where the larger pectoral ...
Freelance writer Amanda C. Kooser covers gadgets and tech news with a twist for CNET. When not wallowing in weird gear and iPad apps for cats, she can be found tinkering with her 1956 DeSoto. Fish ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback